Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CRHR1 | P34998 | 3/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5355585 | 0.89 | MAPT (0.50) | MAPTSMN1; SMN2CRHR1MEN1KMT2A | |
| SCHEMBL469846 | 0.89 | MAPT (0.35) | MAPTSMN1; SMN2DNM1TSHRSLC29A1 | |
| SCHEMBL21081373 | 0.84 | MAPT (0.47) | MAPTSMN1; SMN2CRHR1DNM1MEN1 | |
| Butylamine SCHEMBL6421996 | 0.83 | CRHR1 (0.35) | MAPTSMN1; SMN2CRHR1DNM1MEN1 | |
| SCHEMBL2535675 | 0.81 | MAPT (0.48) | MAPTSMN1; SMN2CRHR1DNM1TSHR | |
| Ethylenediamine SCHEMBL7196307 | 0.80 | CRHR1 (0.36) | MAPTSMN1; SMN2CRHR1MEN1KMT2A | |
| SCHEMBL12109976 | 0.80 | CRHR1 (0.57) | MAPTSMN1; SMN2CRHR1MEN1KMT2A | |
| SCHEMBL21427481 | 0.79 | SLC29A1 (0.47) | SMN1; SMN2CRHR1KMT2ASLC29A1CYP1A2 | |
| SCHEMBL11798265 | 0.79 | SLC29A1 (0.43) | SMN1; SMN2CRHR1KMT2ASLC29A1CYP1A2 | |
| SCHEMBL523376 | 0.78 | MAPT (0.42) | MAPTSMN1; SMN2CRHR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120063976-A1 | METHODS OF REMOVING CARBON DIOXIDE AND SORBENTS FOR SAME | BATTELLE ENERGY ALLIANCE, LLC (US) | 2012-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120063976-A1 | METHODS OF REMOVING CARBON DIOXIDE AND SORBENTS FOR SAME | CHRM2, CHRM1, CHRM3 | MAPT 3538/4885SMN1; SMN2 1298/4885CRHR1 560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.